RxDoctor Payments Data

Amy Ladewski, PA

Physician Assistant · Chicago, ILNPI 1083055180

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Ardelyx, Inc. at 52.0% of the total. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,222in general payments, 2019–2025

Across 112 payments — averaging $260.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ardelyx, Inc.$15K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
  • AbbVie$3K
  • Phathom Pharmaceuticals, Inc.$3K
  • Novo Nordisk$1K
  • Gilead$1K
  • plus $524 from 4 others

What the payments were for

  • Consulting fees$17,46060%
  • Speaking & faculty fees$5,43719%
  • Travel & lodging$3,48812%
  • Food & beverage$2,83710%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,222 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$15,218
Medicare patients
103
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide109$119,632
IbsrelaTenapanor Hcl36$82,809
MotegrityPrucalopride Succinate54$57,822
Lansoprazole20$17,197
TrulancePlecanatide15$16,724
Aprepitant11$12,136
MovantikNaloxegol Oxalate27$11,315
Dexlansoprazole DrDexlansoprazole26$6,410
Omeprazole98$1,994
Pyridostigmine Bromide11$1,018
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates15$854
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg35$830
Famotidine28$734
Nortriptyline Hcl23$256
Esomeprazole Magnesium14$234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$3,087$119,632109 claims
Ardelyx, Inc.Ibsrela$15,210$82,80936 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$5,059$16,72415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →